Fact CheckerSign in

NCT06008041Active, not recruiting

Multimodal Epicardial and Endocardial COronary PHYsiological Evaluation in Pathological Situations (PHYCO)

Multimodal Epicardial and Endocardial COronary PHYsiological Evaluation in Pathological Situations

Source: ClinicalTrials.gov · Last updated 28 Aug 2023

Brief summary (registry, in English)

When performing coronary angiography in a stable situation, the identification of an intermediate coronary lesion (between 50 and 70%) is common, and requires additional functional evaluation. The gold standard for this evaluation is Fractional Flow Reserve (FFR). FFR is a flow ratio transformed into a pressure ratio by simplification, neglecting some parameters, especially microcirculatory resistance. The aim of this study is to investigate hemodynamic and structural assessment induced in specific conditions, and their repercussion on functional assessment by FFR to implement the diagnostic approach and personalize it for each patient.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
400 (estimated)
First submitted
16 Aug 2023
Start date
Jul 2023
Primary completion date
Jul 2023
Lead sponsor
University Hospital, Brest
NCT number
NCT06008041

What you commit to

  • Study type: Observational
  • Planned participants: 400
  • From Jul 2023 to the primary completion date, Jul 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Adenosine hypersensitivity
  • Severe chronic obstructive pulmonary disease
  • Carotid artery stenosis with hemodynamic insufficiency

Lab values

  • Long QTc

Other

  • Hemodynamic instability
  • Asthma
  • Wolff parkinson white
  • High degree atriovenricular block
  • Left-right shunt
  • Pregnancy

Who the study is looking for

  • Intermediate coronary lesion (between 50 and 70%)

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chu Brest
Coordinator of this site? Confirm its status
BrestFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.